Figure 4
Ixazomib pharmacokinetic profiles in cycle 1, according to dose. Mean plasma day 1 (A) and day 15 (B) concentration–time profiles; (C-D) geometric mean (%CV) day 1 and day 15 plasma Cmax and AUC0–168hr. Cmax, peak concentration.
Ixazomib pharmacokinetic profiles in cycle 1, according to dose. Mean plasma day 1 (A) and day 15 (B) concentration–time profiles; (C-D) geometric mean (%CV) day 1 and day 15 plasma Cmax and AUC0–168hr. Cmax, peak concentration.
